| This article illustrates the scientific evidence driving the clinical management of patients affected by actinic keratosis, aiming to provide a patient-tailored treatment program. |
| Phase II/III clinical trials are showing promising results from new topical agents. |
| The goals of actinic keratosis treatment are to eradicate as many clinical and subclinical lesions as possible, achieve as prolonged a clinical remission as possible, provide a good cosmetic result, and prevent progression to invasive squamous cell carcinoma. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.